Talis Biomedical Corp (TLIS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 21,604 |
| Receivables | 0 | 0 | 0 | 1,806 |
| Other current assets | 0 | 0 | 0 | 697 |
| TOTAL | $0 | $0 | $0 | $24,107 |
| Non-Current Assets | ||||
| PPE Net | N/A | N/A | N/A | 3,770 |
| Other Non-Current Assets | 0 | 0 | 0 | 91 |
| TOTAL | $N/A | $N/A | $N/A | $3,861 |
| Total Assets | $0 | $0 | $0 | $25,733 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 1,566 |
| Accrued Expenses | 0 | 0 | 0 | 2,471 |
| TOTAL | $0 | $0 | $0 | $4,037 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 42,836 |
| TOTAL | $N/A | $N/A | $N/A | $42,836 |
| Total Liabilities | $0 | $0 | $0 | $46,873 |
| Shareholders' Equity | ||||
| Retained earnings | 0 | 0 | 0 | -81,776 |
| TOTAL | $0 | $0 | $0 | $-21,140 |
| Total Liabilities And Equity | $0 | $0 | $0 | $25,733 |